Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

VERU Relative to the S&P 500

VERU Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Veru Inc. (NASD:VERU) seasonal charts above shows that a Buy Date of November 16 and a Sell Date of February 12 has resulted in a geometric average return of 10.42% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 23.84% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Consumer Staples sector, which runs from April 25 to November 23. The seasonal chart for the broad sector is available via the following link: Consumer Staples Sector Seasonal Chart.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of?breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.

To download VERU seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: VERU